Product News
Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies
Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
Product News
Sartorius Forms Partnership With Sparta Biodiscovery on Novel Nanoparticle Analysis Platform
SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs.
Product News
Thermo Fisher Freezers Now ISO Class 5.5 Designated for CGT Applications
Thermo Fisher Scientific TSX and TDE Series ultra-low freezers are tested according to ISO 14644-14 and designated ISO Class 5.5; operational; 0.1 μm, 0.2 μm, 0.3 μm, 0.5 μm, 1.0 μm, contributing to the safe and effective development of therapies.
Product News
Integrated DNA Technologies and Aldevron® Activate Strategic Partnership
Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic.
Product News
New Cell & Gene Therapy Solutions From Form Bio Analyze Billions of Potential Construct Candidates
Form Bio, announced capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates.
Product News
Ganymede Bio and Kytopen Partner To Bring Cloud-Native, Structured Data to Gene-Modified Cell Therapy Instruments
Ganymede Bio and Kytopen have announced a partnership to bring the power of cloud-native, structured data to Kytopen’s Flowfect® platforms.
Product News
Curiox Biosystems To Advance Next-Generation Cancer Cell Therapies Through Collaboration With Leading Cancer Researcher
Curiox Biosystems announces its collaboration with Dr. Marco Ruella, an assistant professor of medicine at the Perelman School of Medicine, to support efforts in the development of next-generation cancer cell therapies.
Product News
Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine
Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Product News
Accelerating Cell Therapies with Manufacturing Breakthrough
Thermo Fisher announced a first of its kind technology to help accelerate the molecule-to-market process by driving efficiency and reducing manufacturing costs.
Product News
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration
TherageniX, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery.
Advertisement